Pennsylvania health officials have ruled that Geisinger Medical Center failed to follow standard infection control procedures, which led to the death of 3 premature infants last year, the Associated Press reported.
The findings are the result of a surprise state inspection that occurred in October, which determined that the bacterium Pseudomonas was behind the outbreak at Geisinger’s hospital in Danville, Pennsylvania. The facility was cleared to begin treating premature infants in its neonatal intensive care unit again on December 6 after it corrected the problems.
Those problems included failing to keep donor breast milk at the correct temperature and routinely testing equipment for bacteria. In addition, Geisinger stored equipment within the “splash zone” of a sink and didn’t have written instructions for routine cleaning of brushes, blenders, cylinders, and other equipment used to prepare infant formula and breast milk.
Pseudomonas aeruginosa bacteria are common but can pose a hazard to vulnerable patients, including “severe nosocomial infections, life-threatening infections in immunocompromised persons, and chronic infections in cystic fibrosis patients,” according to the US Centers for Disease Control and Prevention. “The bacterium’s virulence depends on a large number of cell-associated and extracellular factors. Cell-to-cell signaling systems control the expression and allow a coordinated, cell-density–dependent production of many extracellular virulence factors.”
When contacted by Infection Control Today, Geisinger spokesperson Matthew Van Stone said that “due to ongoing litigation, it would be inappropriate for us to comment at this time.”
Frank Maffei, MD, Geisinger’s chair of pediatrics, said at a news conference in October that “our neonatal intensive care unit has never seen a situation involving infections like this. Our neonatal intensive care unit has been a cornerstone of our children's hospital for 25 years. The unit has provided excellent care for the tiniest of babies.”
Geisinger has issued apologies for the infection, which state health inspectors said happened as a result of the hospital not routinely sanitizing the equipment used to prepare donor breast milk.
According to the AP, Geisinger’s actions placed vulnerable patients in “immediate jeopardy,” a legal finding that means risk of serious injury or death.
Matt Casey represents the families of 2 of the babies who died. He said: “This is an institution that holds itself out as a facility that has specific expertise in caring for premature babies, and this report demonstrates that there was a flagrant disregard of the most basic infection control policies.”
Geisinger said in a statement: “The teams at Geisinger Medical Center look forward to providing high-quality, life-saving care to our communities’ most fragile infants.”
From the Derby to the Decontam Room: Leadership Lessons for Sterile Processing
April 27th 2025Elizabeth (Betty) Casey, MSN, RN, CNOR, CRCST, CHL, is the SVP of Operations and Chief Nursing Officer at Surgical Solutions in Overland, Kansas. This SPD leader reframes preparation, unpredictability, and teamwork by comparing surgical services to the Kentucky Derby to reenergize sterile processing professionals and inspire systemic change.
Show, Tell, Teach: Elevating EVS Training Through Cognitive Science and Performance Coaching
April 25th 2025Training EVS workers for hygiene excellence demands more than manuals—it requires active engagement, motor skills coaching, and teach-back techniques to reduce HAIs and improve patient outcomes.
The Rise of Disposable Products in Health Care Cleaning and Linens
April 25th 2025Health care-associated infections are driving a shift toward disposable microfiber cloths, mop pads, and curtains—offering infection prevention, regulatory compliance, and operational efficiency in one-time-use solutions.
Phage Therapy’s Future: Tackling Antimicrobial Resistance With Precision Viruses
April 24th 2025Bacteriophage therapy presents a promising alternative to antibiotics, especially as antimicrobial resistance continues to increase. Dr. Ran Nir-Paz discusses its potential, challenges, and future applications in this technology.